Adjuvant factors in DNA vaccines
Spitz, M.és.; Velikovsky, C.A.; Cassataro, J.; Giambartolomei, G.H.
Medicina 62(1): 99-102
2002
ISSN/ISBN: 0025-7680 PMID: 11965860 Document Number: 549352
Document emailed within 1 workday
Related Documents
Mishra, N.; Gupta, P.N.; Mahor, S.; Khatri, K.; Goyal, A.K.; Vyas, S.P. 2007: Liposomes as adjuvant for combination vaccines Indian Journal of Experimental Biology 45(3): 237-241Fiejka, M.; Aleksandrowicz, J. 1993: Aluminum as an adjuvant in vaccines and post-vaccine reactions Roczniki Panstwowego Zakladu Higieny 44(1): 73-80
Gendon, I.Z.; Markushin, S.G.; Krivtsov, G.G.; Akopova, I.I. 2008: Chitosan as an adjuvant for parenteral inactivated influenza vaccines Voprosy Virusologii 53(5): 14-19
Perkins, F.T. 1972: Experience in the United Kingdom with oil adjuvant influenza vaccines Annals of Allergy 30(5): 288-291
McKeon, F.W. 1976: A recent trial comparing two 45/20 adjuvant Brucella vaccines Developments in Biological Standardization 31: 343-350
Uede, T.; Huff, T.F.; Ishizaka, K. 1982: Formation of IgE-binding factors by rat T lymphocytes. V. Effect of adjuvant for the priming immunization on the nature of IgE binding factors formed by antigenic stimulation Journal of Immunology 129(4): 1384-1390
Sarateanu, D.E.; Ehrengut, W. 1981: Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines Fortschritte der Medizin 99(34): 1348-1352
Ferrer Aguareles, Jé.Luis.; Ruiz Muñoz, E. 2011: Vaccines and nurses, key factors in prevention Revista de Enfermeria 34(11): 4-5
Peetermans, J. 1996: Factors affecting the stability of viral vaccines Developments in Biological Standardization 87: 97-101
Trollfors, B. 1997: Factors influencing antibody responses to acellular pertussis vaccines Developments in Biological Standardization 89: 279-282
Lemons, A.R.; Naz, R.K. 2011: Contraceptive vaccines targeting factors involved in establishment of pregnancy American Journal of Reproductive Immunology 66(1): 13-25
Kawabata, R.; Imamura, H.; Kishimoto, T.; Hachino, Y.; Yasui, Y.; Fujino, M.; Fujii, C.; Fukunaga, M.; Ohzato, H.; Furukawa, H. 2012: Examination of factors influencing continuity of S-1 adjuvant chemotherapy for gastric cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(8): 1205-1208
Zincke, H. 1997: Adjuvant treatment after radical prostatectomy in prostatic carcinoma (pT3 or pTxN+): prognostic factors and results Praxis 86(46): 1825-1832
Jeon, S.H.; Chang, S.G.; Kim, J.I. 1999: The role of adjuvant immunotherapy after radical nephrectomy and prognostic factors in pT3N0M0 renal cell carcinoma Anticancer Research 19(6c): 5593-5597
Kuru, B. 2011: Prognostic factors for locoregional recurrence and survival in stage IIIC breast carcinoma: impact of adjuvant radiotherapy Singapore Medical Journal 52(4): 289-298
Byfield, P.E.; Finklestein, J.Z.; Tittle, K.L.; Hsi, C.; Imagawa, D.T. 1975: The role of serum factors in the acceleration by Freund's complete adjuvant of the growth of transplanted murine leukemic cells Cancer Research 35(2): 409-414
Houssay, R.H.; Eugui, E.M. 1971: Effect of previous subliminal doses of mycobacterial adjuvant on adjuvant disease Medicina 31(4): 281-288
Yamaguchi, M.; Fukuyama, Y.; Ichinose, Y. 2003: Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(2): 203-208
Keith, J.A.; Agostini Bigger, L.; Arthur, P.A.; Maes, E.; Daems, R. 2013: Delivering the promise of the Decade of Vaccines: opportunities and challenges in the development of high quality new vaccines Vaccine 31(Suppl 2): B184-B193
Yoshikawa, T.; Kitamura, Y.; Uchida, N.; Yamaguchi, K.; Matsumoto, K. 1983: Effect of adjuvant endocrine and adjuvant chemoendocrine therapies on metastasis of androgen-dependent Shionogi carcinoma 115 Cancer Research 43(10): 4525-4529